The result showed that pancreatic cancer patients with a high proportion of SPP1+ macrophages had a significantly shorter survival, indicating the important role of SPP1+ macrophages in pancreatic cancer progression and patient prognosis (Figure 6I). This evidence concerns the gene SPP1 and pancreatic neoplasm.